Frances Rudnick Levin

Phoenix Pharmalabs, Inc.

NIH Rank #1603
  • Program Leader
  • Top 10% Funded
  • Early Career
  • Mentor

NIH Funding · FY2024

Total Funding
$4M
Fiscal year 2024
Grants Awarded
2
Active NIH grants
National Rank
#1,603
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $4M across 2 grants · National rank #1603.

Top grants by award amount

Frances Rudnick Levin's NIH grant portfolio, ranked by award amount.

  • 5U01DA057862-03U01
    Development of PPL-138, a Novel Mixed NOP/Mu Partial Agonist for Treatment of CocaineUse Disorder
    $3.6M
    award amount
  • 5T32DA007294-32T32
    Translational Clinical Research Fellowship on Substance Use Disorders
    $412.9K
    award amount

Affiliations

Institutions that have administered grants for Frances Rudnick Levin.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Phoenix Pharmalabs, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #1603
  6. 2024
    Entered Top 25% Nationally
    Ranked #1603
  7. 2024
    Entered Top 10% Nationally
    Ranked #1603
  8. 2024
    Multi-Institutional Research
    Awards at 2 institutions

Related investigators

Other NIH-funded PIs frequently associated with Frances Rudnick Levin.